Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Glimepiride Orally Disintegrating Tablets

Approval Number

国药准字H20080704

Company武汉维奥制药有限公司

Registration Date

January 5, 2023

Previous Approval Numbers

国药准字H20080704

Drug Information

Generic Name

格列美脲口腔崩解片

Brand Name

维博安

Dosage Form

片剂

Strength

2mg

Drug Type

化学药品

Registration Date

January 5, 2023

Company Information

Applicant Company

Company Name武汉维奥制药有限公司

Company Address

湖北省武汉市东湖新技术开发区江夏大道武大科技园

Manufacturing Company

Company Name武汉维奥制药有限公司

Company Address

湖北省武汉市东湖新技术开发区江夏大道武大科技园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy